{
  "content": "Diagnosis:\t\nBilateral mammary carcinoma, initial left mastectomy with level I/II axillary dissection 2008 followed by chest wall radiotherapy and tamoxifen; subsequent right-sided completion mastectomy 2012.\n\nInitiated anastrozole January 2022 - developed local recurrence\nSkin punch biopsy confirms Grade 2 invasive ductal carcinoma, ER 8/8, PR positive, HER2 negative\n\nBreast MDT Discussion\n\nImaging: PET-CT comparison with January demonstrates increased metabolic activity right anterior chest wall with associated inflammatory changes. No evidence of distant metastatic disease.\n\nMDT recommendation: Consider switch to alternative endocrine therapy with addition of CDK4/6 inhibitor\n\nSeen with [redacted name].\n\nSubjectively noting increased firmness and discomfort of right chest wall with progressive skin changes.\nNo systemic symptoms.\nNo other cancer-related concerns.\n\nPMH: Drug-induced hypothyroidism on replacement\nSteroid-induced osteoporosis on denosumab\nMild cognitive impairment\n\nMedications: Current anastrozole, levothyroxine, denosumab 6-monthly, calcium/vitamin D supplementation\n\nSocial History: Lives in sheltered accommodation\nFormer teacher\nWidowed, daughter lives nearby providing support\nNever smoker\n\nPerformance Status 1\nBP 136/82\nLeft chest wall shows well-healed mastectomy scar\nRight chest wall demonstrates patchy induration with periareolar changes affecting approximately 40% of surface area\nNo palpable supraclavicular nodes\nChest clear\nRegular cardiac rhythm\nSoft, non-tender abdomen\nNo ankle swelling\n\nDiscussed disease progression on current endocrine therapy. Explained rationale for changing treatment to exemestane with palbociclib. Patient expressing understanding but requesting time to consider options.\n\n[redacted name] to attend next consultation with family. Written information provided about proposed treatment regimen. Emergency oncology contact details given.\n",
  "output": {
    "primary_cancer": {
      "site": "breast, bilateral",
      "year": 2008,
      "metastases": "local recurrence in right chest wall",
      "biomarker_status": "ER 8/8, PR positive, HER2 negative",
      "histopathology_status": "Grade 2 invasive ductal carcinoma",
      "cancer_timeline": [
        {
          "type": "treatment_surgery",
          "value": "left mastectomy with level I/II axillary dissection followed by chest wall radiotherapy and tamoxifen",
          "year": 2008
        },
        {
          "type": "treatment_surgery",
          "value": "right-sided completion mastectomy",
          "year": 2012
        },
        {
          "type": "treatment_systemic_start",
          "value": "Initiated anastrozole",
          "year": 2022,
          "month": 1
        },
        {
          "type": "laboratory_finding",
          "value": "Skin punch biopsy confirms Grade 2 invasive ductal carcinoma, ER 8/8, PR positive, HER2 negative"
        },
        {
          "type": "anatomical_finding",
          "value": "PET-CT shows increased metabolic activity right anterior chest wall with associated inflammatory changes, no distant metastatic disease",
          "year": 2022,
          "month": 1
        }
      ]
    },
    "patient_facts": [
      {
        "type": "performance_status",
        "value": "Performance Status 1"
      },
      {
        "type": "current_symptom",
        "value": "increased firmness and discomfort of right chest wall with progressive skin changes"
      },
      {
        "type": "examination_finding",
        "value": "Right chest wall demonstrates patchy induration with periareolar changes affecting approximately 40% of surface area"
      },
      {
        "type": "comorbidity",
        "value": "Drug-induced hypothyroidism on replacement"
      },
      {
        "type": "comorbidity",
        "value": "Steroid-induced osteoporosis on denosumab"
      },
      {
        "type": "comorbidity",
        "value": "Mild cognitive impairment"
      }
    ],
    "status_updates": [
      {
        "type": "clinical_summary",
        "value": "Long-term breast cancer survivor with bilateral mastectomies (2008, 2012) now presenting with biopsy-proven local recurrence while on anastrozole. Patient clinically stable but showing disease progression on examination with right chest wall changes, being considered for exemestane/palbociclib combination therapy."
      },
      {
        "type": "latest_treatment_response",
        "value": "Disease progression on current endocrine therapy with local recurrence"
      },
      {
        "type": "update_to_treatment",
        "value": "Proposed change to exemestane with palbociclib"
      },
      {
        "type": "follow_up_referral",
        "value": "To attend next consultation with family"
      }
    ]
  }
}